The Proliferation of Unvalidated Healthcare Diplomas in French Universities Raises Alarms Among Medical Experts and Public Health Authorities

A growing trend of French universities offering diplomas in non-conventional healthcare practices (PSNCs), often referred to as "soft," "complementary," or "alternative" medicines, is sparking significant concern within the scientific and medical communities. These practices, which the Ministry of Health explicitly states are "neither scientifically recognized by ‘conventional’ medicine nor taught during the initial training of health professionals," are increasingly finding a foothold in higher education institutions, including medical and pharmacy faculties. This phenomenon, which critics describe as "real entryism," threatens to erode academic credibility, confuse the public, and pose potential public health risks.

Defining Non-Conventional Healthcare Practices and Their Status

Non-conventional healthcare practices encompass a broad spectrum of therapies and approaches that fall outside the domain of mainstream, evidence-based medicine. While the World Health Organization (WHO) has identified over 400 such practices globally, their mere enumeration does not imply scientific validation or endorsement by conventional medical standards. In France, the Ministry of Health maintains a clear distinction: PSNCs lack scientific recognition and are not integrated into the foundational curriculum for medical professionals. This fundamental divergence forms the crux of the current controversy. The debate is not merely about the existence of these practices but about their inclusion and legitimization within academic institutions traditionally dedicated to rigorous, evidence-based scientific inquiry.

Historically, interest in alternative therapies has surged in many parts of the world, often driven by a desire for more personalized care, a perceived holistic approach, or dissatisfaction with conventional medicine’s limitations. However, integrating these practices into university curricula without robust scientific validation raises serious questions about academic integrity and public trust.

An Alarming Surge in "Deviant" University Diplomas

The scale of this "entryism" is striking. According to Hugues Gascan, president of the Study Group on Sectarian Phenomena (GEPS) and a biology researcher, the number of "deviant" university diplomas (DUs) or inter-university diplomas (DIUs) has dramatically escalated. From 101 such programs in 2015, the figure is projected to reach 203 by 2025. Gascan meticulously cataloged these problematic courses across various universities, noting that while primarily aimed at medical professionals, they are not exclusively so, and crucially, they are not recognized by the State.

The types of diplomas offered span a wide range of PSNCs, reflecting the diverse landscape of alternative therapies. Examples include:

• "Phytotherapy Aromatherapy" DUs at universities in Besançon, Grenoble, and Montpellier. These practices involve the use of plant extracts and essential oils, often with claims of therapeutic benefits that may or may not be scientifically substantiated.
• "Homeopathy" DUs at Aix-Marseille and Poitiers. Homeopathy, a system based on the principle of "like cures like" using highly diluted substances, has been widely debunked by scientific consensus for its lack of efficacy beyond the placebo effect.
• "Auriculotherapy" DUs at Paris-Saclay and Strasbourg. This therapy involves stimulating points on the outer ear, often using needles, with claims of treating various conditions throughout the body.
• "Musicotherapy" DUs at Nantes and Toulouse. While music can have therapeutic benefits, particularly in mental health and rehabilitation, its academic framing within a medical faculty as a "conventional" treatment without strict scientific validation for all its claimed applications is questioned.
• "Medical Hypnosis" DUs at Rennes and Saint-Étienne. Hypnosis is one of the PSNCs that has garnered some scientific interest for specific applications, particularly in pain management and anxiety, though its integration requires careful delineation of validated uses.

Universities frequently cited for offering the highest number of these programs include Montpellier, Strasbourg, Nancy, Nantes, and Grenoble, indicating a widespread institutional engagement with these controversial practices.

Expert Voices and Profound Criticisms

The growing presence of these unvalidated diplomas has drawn sharp criticism from leading medical and scientific figures. Mathieu Molimard, president of the French Society of Pharmacology and Therapeutics, articulates a clear demand for accountability: "We need to clean up: either the practice is scientifically validated, and it is medicine, or it is not, and we can research it but not teach it." He warns against the significant risk of "confusion" among the public, who might perceive university-endorsed PSNCs as legitimate medical treatments. This confusion can lead to patients choosing unproven therapies over effective conventional treatments, potentially delaying necessary care and exacerbating health conditions.

Hugues Gascan from GEPS further elaborates on the detrimental impact: "This taints the credibility and reliability of the higher education system." He also raises critical questions about "financial aspects" as a potential motivator for cash-strapped universities. With training costs ranging between 1,500 and 5,000 euros, these diplomas could represent a significant revenue stream for institutions struggling with underfunding, creating a perverse incentive to offer courses regardless of their scientific merit.

Dr. Hélène Harmand-Icher, president of the public health section of the French National Medical Council (Ordre des Médecins), echoes these concerns, stating unequivocally, "This is a public health issue." She highlights the "progressive entryism" and confirms that her institution is undertaking a comprehensive review and classification of these practices. Dr. Harmand-Icher draws a crucial distinction: while some PSNCs, such as acupuncture, are reserved for medical doctors and are "framed by the Ordre," leading to "ordinal recognition" and allowing doctors to list them on their professional credentials, others are "open to non-medical professionals, which poses a real problem." She explains that "the ‘medical faculty’ label confers an unfounded medical legitimacy in the eyes of the public" when applied to courses for non-doctors, misleading patients into believing these practitioners have a medical background and their therapies are medically sanctioned.

A Complex Landscape of Views and Institutional Responses

While the criticism is robust, the landscape of opinion within the academic and medical communities is not entirely monolithic. Professor Philippe Ruszniewski, honorary dean of the Faculty of Medicine at Paris Cité University, expresses a nuanced view. He sees "no inconvenience" in DUs for acupuncture, hypnosis, or mindfulness meditation, particularly for "uses validated in certain indications." This acknowledgment suggests a recognition that some PSNCs might have limited, evidence-based applications. However, he sharply contrasts this with practices like naturopathy, aromatherapy, or homeopathy, stating he "does not see how one can authorize a DU" for them, underscoring the divide between potentially beneficial adjunctive therapies and those lacking scientific foundation.

The leadership of medical faculties is also beginning to acknowledge the problem. Marc Humbert, vice-president of the Conference of Deans of Medicine and dean of the Faculty of Medicine at Paris-Saclay University, admits to "failures" that need to be "identified and corrected." He indicates that Paris-Saclay is actively engaged in "evaluation work" for certain programs, including the DIU in auriculotherapy, with decisions expected "in the coming weeks." This proactive stance signals a potential shift towards greater scrutiny from within the academic establishment.

Timeline and Official Inertia

The chronology of this issue highlights a persistent gap between expert recommendations and official policy. In January, a report co-authored by Professor Molimard was submitted to the government. This report strongly advocated for "banning the academic labeling of unvalidated care practices" and called for a thorough "audit of existing training programs." However, in a significant oversight that has frustrated many experts, the Ministry of Health did not incorporate this crucial recommendation into its broader strategy for combating health disinformation. This omission suggests a reluctance at the ministerial level to directly confront the issue of academic legitimization of unproven therapies, despite the clear public health implications.

The lack of decisive governmental action places the onus on academic institutions themselves. The upcoming session of the Conference of Deans of Medicine is poised to address PSNCs directly. Marc Humbert announced that the deans will "request an inventory of training programs, as well as the audit and withdrawal of training programs on unvalidated care practices." This collective move by the deans could mark a turning point, signaling a unified effort to restore scientific rigor to medical education. Professor Molimard’s assertion that "it is time for institutions to take their responsibilities" resonates strongly in this context.

Broader Impact and Implications for Public Health and Academic Integrity

The implications of this trend extend far beyond academic debates. At stake are fundamental principles of public health, patient safety, and the integrity of scientific education.

• Public Health Concerns: When universities lend their imprimatur to unvalidated therapies, the public receives a misleading message. Patients, often vulnerable and seeking relief, may interpret a university diploma as a guarantee of efficacy and safety, potentially leading them to forgo or delay conventional, evidence-based treatments. This can have severe consequences, especially for serious or progressive diseases. Furthermore, the financial burden on individuals seeking these unproven treatments, which can cost thousands of euros, adds another layer of public health concern.
• Academic Credibility: The primary mission of a university, especially a medical faculty, is to advance and disseminate knowledge based on rigorous scientific methodology. Offering diplomas in practices that lack scientific validation undermines this mission, blurring the lines between legitimate medical science and speculative or disproven therapies. It can dilute the academic rigor of an institution and damage its reputation, both nationally and internationally.
• Professional Standards: For healthcare professionals, the availability of university-endorsed PSNC diplomas creates confusion regarding professional standards and scope of practice. While some practices may have a role as complementary therapies when integrated judiciously by trained medical professionals, the proliferation of unvalidated courses, particularly those open to non-medical practitioners, risks promoting unqualified or misleading advice.
• Resource Allocation: The allocation of university resources—faculty time, administrative support, and institutional funding—to programs of questionable scientific merit diverts resources that could otherwise be invested in cutting-edge research, evidence-based medical education, or areas of high public health priority.

Conclusion: A Call for Renewed Vigilance and Action

The burgeoning number of university diplomas in non-conventional healthcare practices in France represents a significant challenge to academic integrity and public health. While the desire for holistic care and alternative options is understandable, the integration of these practices into university curricula must be governed by the same stringent scientific standards applied to conventional medicine. The strong condemnations from leading medical societies, the detailed analysis by watchdog groups, and the emerging commitment from medical deans underscore the urgency of the situation. Without clear, robust, and consistent action from both academic institutions and governmental bodies, the risk of public confusion, misdirected care, and the erosion of scientific credibility will continue to grow, making it imperative that institutions take decisive steps to align their educational offerings with the principles of evidence-based medicine.